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Introduction 42
Cleft palate is the most common congenital anomalies in humans, and its etiology is complex (Dixon et 43 al., 2011; Murray, 2002) . The palate is derived from the primary and secondary palate, which are located 44 in the anterior and posterior portions of the palate, respectively (Gu et al., 2008) . Palatal fusion is 45 essential in palatogenesis, and its defect leads to cleft palate. Two halves of the palatal process fuse in 46 the middle to form the secondary palate, which further fuse with the primary palate and the nasal septum 47 to form the definite palate (Ferguson, 1988) . Our previous study has shown that pharmaceutical application of Stat3 inhibitors disturbs the palatal 81 fusion with downregulation of Tgfb3. Hence, it was assumed that folic acid might be a useful therapy for 82 preventing the cleft palate via the extrinsic modification of Stat3 activation to prevent cleft palate. 83
84
We herein report the first evidence that Cbfb is essential in anterior palatogenesis as an obligatory 85 cofactor in the Runx1/Cbfb-Stat3-Tgfb3 signaling axis. In addition, we also demonstrate the rescue of 86 mutant cleft palate via pharmaceutical folic acid application, at least in part, by activating Stat3 87 phosphorylation in the Runx1/Cbfb-Tgfb3 signaling axis during palatogenesis. 88 7 The proliferative activity was evaluated using Ki67 staining. Double-staining for Ki67 and K14 114 immunoreactivity showed that Ki67-positive proliferating cells were sparse at the fused epithelium in 115 wild-types ( Fig. 2C ), whereas some immunoreactivity was retained in the epithelium in Cbfb mutants 116 ( Fig. 2D ). Ki67-positive cells were quantified from the images and we found that the percentage cells 117 for Ki67 in the mutants was significantly higher than in the wild-type palates ( Fig. 2E ). 118 119 TUNEL assay showed that apoptotic signals were evident in the fused epithelium in controls ( Fig. 2F) , 120
whereas far fewer signals were detected on the unfused epithelium of the Cbfb mutants ( Fig. 2G ). 121 TUNEL-positive cells were quantified from the images and we found and TUNEL-positive cells at the 122 fusing epithelium was significantly reduced in percentage in the mutants than in the controls ( The whole-mount in situ hybridization showed that Cbfb transcripts were widely distributed along the AP 138 axis and not specifically in the anterior regions at E14.0 ( Fig. 3A,B ). The distribution of the Cbfb mRNA 139 expression therefore does not explain why Cbfb deficiency caused an anterior-specific phenotype in 140 palatogenesis. Sliced sections revealed that Cbfb transcripts were present in both the palatal epithelium 141 and mesenchymal tissue (Fig. 3C ). The Runx1 expression was intense in the fusing region of the palatal 142 shelves and in the primary palate regions (Fig. 3D ), and the Runx2 expression was present in the fusing 143 region of the palatal process, however, Runx2 expression was lower in the primary palate region than 144 the secondary palate ( Fig. 3E ), as previously reported (Charoenchaikorn et al., 2009) . Runx3 was also 145 detected in the fusing region of the palatal process ( Fig. 3F ). 146 147
Altered mRNA expression in Cbfb mutant palate. 148
To clarify the molecular mechanisms underlying the failed palatal fusion in Cbfb mutants, we evaluated 149 the changes in several molecules that have been recognized as anterior-specific genes in palatogenesis. In our previous study using Runx1 mutant mice, we demonstrated that Stat3 phosphorylation was 178 disturbed by Runx1 deficiency in the anterior region of the palate (Sarper et al., 2018). We therefore 179 explored whether or not the Stat3 activity is affected during anterior palatal fusion in Cbfb mutants. 180 181 Immunoreactivity to Stat3 was present in the palatal epithelium, and some immunoreactivity was also 182 observed in the mesenchyme (Fig.5A ). Cbfb deficiency did not affect the Stat3 immunoreactivity 183 ( Fig.5B ). In contrast, immunoreactivity to pStat3 was detected in the fusing or fused epithelium in wild-184 type ( Fig. 5C ), whereas pStat3 was remarkably downregulated in the primary palate in Cbfb mutants 185 ( Fig. 5D ). A western blot analysis revealed a significant reduction in the immunoreactivity to pStat3 in the 186
Cbfb mutant primary palate, while that to Stat3 was not affected (Fig. 5E ).
188

Rescue of cleft palate of Cbfb mutants by folic acid. 189
We then attempted to rescue the mutant cleft palate using folic acid application. A recent study showed 190 that folic acid and folate activate STAT3 pathway ( Taken together, these findings show that folic acid rescued the cleft palate of Cbfb mutants, presumably 235 through the activation of Stat3. Furthermore, the rescue of the mutant cleft palate using folic acid may 236 elucidate potential therapeutic targets by Stat3 modification for the prevention and pharmaceutical 237 intervention of cleft palate (Fig. 7D) . 238
239
In conclusion, the present study demonstrated that Cbfb is essential for anterior palatogenesis as an 240 obligatory cofactor of Runx1/Cbfb signaling (Fig. 7A ). In addition, we also demonstrate the rescue of 241 mutant cleft palate via pharmaceutical folic acid application, at least in part, by activating Stat3 242 phosphorylation in the Runx/Cbfb-Tgfb3 signaling axis during palatogenesis (Fig.7D) . 243
Materials and Methods 244
Animals 245
Cbfb −/− mice are early lethal due to hemorrhaging between E11.5 and E13.5, when the palatal 246 development is not yet initiated (Sasaki et al., 1996) . To assess the role of Cbfb in the oral epithelium, 247
we use epithelial-specific knock-out mice created through the Cre/loxP system (K14-Cre/Cbfb fl/fl ), as 248 described in a previous study (Kurosaka et al., 2011). We used their littermates that did not carry 249 the K14-Cre/Cbfb fl/fl genotype as controls. 250 251
Assessment of palatal fusion and a histological analysis 252
The palatal phenotypes were first evaluated with a dissecting microscope. The percentage of proliferating cells at the fusing or contacting epithelium between the primary and the 270 secondary palate was determined by counting Ki67-positive cells as a percentage of the total number of 271 cells, as determined by DAPI staining. 272
273
Laser microdissection 274
The dissected heads were freshly embedded in OCT compound (Tissue Tek, Sakura) and frozen 275 immediately. Then, tissues were serially sectioned at a thickness of 25 μm on a cryostat (Leica CM 276 1950). Theater, the sections were mounted on a film-coated slide. From the anterior palate at E15.0, 277 12-14 serial sections were obtained on total and stained with Cresyl violet. Palatal tissues at the border 278 between the primary and the secondary palate were dissected from the sample sections using a manual 279 laser-capture microdissection system (LMD6500, Leica) and collected into tubes. 280
281
RNA Extraction and a real-time RT-PCR Analysis 282
Total RNA was extracted from the laser-microdissected tissues or dissected tissues using IsogenII 283 (Nippon Gene, Toyama, Japan) according to the manufacturer's protocol, then reverse transcribed to 284 cDNA using an oligo (dT) with reverse transcriptase (Takara, Osaka, Japan). To evaluate the possible rescue of cleft palate in Cbfb mutants by folic acid application, the palatal 319 explants were cultured for 48 h in BGJb (Gibco) culture medium containing folic acid (N 5 -formyl-5,6,7,8-320 tetrahydropteroyl-L-glutamic acid) (Sigma) at a final concertation of 100 μg/ml. After culture, the in vitro 321 explants were fixed at each stage in 4% paraformaldehyde overnight and then processed for histological 322 observation. 323
324
Western blot analysis 325
For western blotting, the primary palate of Cbfb mutants was dissected and then cut in half. Each half of 326 the explants was cultured with or without folic acid for 48 hours. 327
328
The dissected samples were lysed with RIPA buffer (nacalai tesque) supplemented with protease and 329 phosphatase inhibitors (nacalai tesque). The lysates were centrifuged and the supernatant was heated in 330 denaturing Laemmli buffer (Bio-rad Laboratories). Proteins were separated by SDS-PAGE and 331 transferred to polyvinylidene difluoride membranes (Bio-rad Laboratories). 332
333
The membranes were incubated with anti-Stat3 (1:1000, #9139, Cell Signaling Technology), anti-pStat3 334
(1:1000, #9145, Cell Signaling Technology), anti-β-actin (1:2000, Sigma) or anti-α-tubulin (1:1000, 335 Invitrogen). The bound antibodies were detected with HRP-linked antibody (1:1,000, Cell Signaling 336 Technology) and an ECL detection kit (Bio-rad Laboratories). 337 338
Statistical analyses 339
Quantitative variables in the two groups were compared using the Mann-Whitney U test. Differences 340 among the three groups were determined using the analysis of variance (ANOVA) test, and 341 significant effects indicated by the ANOVA were further analyzed with post hoc Bonferroni correction. 
